Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities.
about
Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodiesEffector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses.Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells.Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat ProteinLack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development.Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection.
P2860
Q24538755-A79B08FD-0D78-4331-BA6A-535630D081F8Q27665884-4D1A3F7C-FA9E-4DE8-B837-74C8AE43A33DQ33870167-4942A5BD-2077-472E-8BBF-A8C16B45BE79Q34982646-F8FAA6CC-0ED8-4F69-84F5-C5F021EA09FDQ35024276-283AF467-C5DF-4BE5-A7E6-5060D1EFCC22Q35913921-E660BB52-9486-40FB-BBB5-08021A57C0FAQ37426168-B0274526-8191-4BEE-B51D-DAC2A82AFA6BQ37592654-1A27AF52-DF62-4F1C-84EE-9CD900DBDD01Q38998925-D2BB8DD2-EE10-4C3C-B3B1-59ABB3C97C03Q42159772-118F5394-8907-47B7-8EF8-E9D51E15F215Q42686885-297D68FD-7B2F-479C-862D-479D63EF0B1C
P2860
Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Antibody-dependent cellular cy ...... fferent epitope specificities.
@en
Antibody-dependent cellular cy ...... fferent epitope specificities.
@nl
type
label
Antibody-dependent cellular cy ...... fferent epitope specificities.
@en
Antibody-dependent cellular cy ...... fferent epitope specificities.
@nl
prefLabel
Antibody-dependent cellular cy ...... fferent epitope specificities.
@en
Antibody-dependent cellular cy ...... fferent epitope specificities.
@nl
P2860
P1433
P1476
Antibody-dependent cellular cy ...... fferent epitope specificities.
@en
P2093
P2860
P304
P407
P577
1998-01-01T00:00:00Z